NANO MRNA Co.,Ltd. Logo

NANO MRNA Co.,Ltd.

Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.

4571 | T

Overview

Corporate Details

ISIN(s):
JP3651120002
LEI:
Country:
Japan
Address:
港区愛宕二丁目5番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NANO MRNA Co., Ltd. is a biotechnology company specializing in the research and development of mRNA-based therapeutics and other nucleic acid medicines. Operating under an "IP Generator" business model, the company functions as a platform connecting drug discovery seeds with medical and development needs. Its core strategy involves creating intellectual property for novel therapies and then licensing them out to pharmaceutical partners for further development and commercialization. NANO MRNA leverages proprietary Drug Delivery System (DDS) technologies to advance its pipeline, which includes candidates for indications such as osteoarthritis and glioblastoma. Formerly Nanocarrier Co., Ltd., the company has repurposed its extensive R&D experience to focus on mRNA drug discovery. In addition to its R&D activities, the company also markets co-developed pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:34
Registration Form
確認書
Japanese 8.2 KB
2025-11-14 07:33
Interim Report
半期報告書-第30期(2025/04/01-2026/03/31)
Japanese 195.4 KB
2025-10-15 08:30
Registration Form
訂正有価証券届出書(参照方式)
Japanese 192.3 KB
2025-10-08 09:22
Registration Form
有価証券届出書(参照方式)
Japanese 205.3 KB
2025-07-18 08:30
Share Issue/Capital Change
臨時報告書
Japanese 28.4 KB
2025-07-01 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-06-30 08:33
Governance Information
内部統制報告書-第29期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-30 08:31
Registration Form
確認書
Japanese 8.1 KB
2025-06-30 08:30
Annual Report
有価証券報告書-第29期(2024/04/01-2025/03/31)
Japanese 906.3 KB
2025-05-14 08:34
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2025-02-14 07:38
Regulatory News Service
臨時報告書
Japanese 18.8 KB
2024-11-18 07:32
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-11-14 07:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-14 07:02
Interim Report
半期報告書-第29期(2024/04/01-2025/03/31)
Japanese 169.1 KB
2024-07-01 08:07
Post-Annual General Meeting Information
臨時報告書
Japanese 22.2 KB

Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NANO MRNA Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR

Talk to a Data Expert

Have a question? We'll get back to you promptly.